ROSETI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.522
EU - Europa 1.165
AS - Asia 206
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
SA - Sud America 1
Totale 2.910
Nazione #
US - Stati Uniti d'America 1.520
IT - Italia 797
UA - Ucraina 120
SE - Svezia 84
TR - Turchia 79
IE - Irlanda 54
VN - Vietnam 47
SG - Singapore 43
DE - Germania 37
CN - Cina 29
GB - Regno Unito 25
CZ - Repubblica Ceca 20
EU - Europa 9
AU - Australia 7
FR - Francia 7
BE - Belgio 6
AT - Austria 5
FI - Finlandia 3
JP - Giappone 3
NL - Olanda 3
CA - Canada 2
HK - Hong Kong 2
IN - India 2
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
LT - Lituania 1
MD - Moldavia 1
SA - Arabia Saudita 1
Totale 2.910
Città #
Milan 490
Fairfield 226
Chandler 123
Woodbridge 117
Ashburn 114
Jacksonville 97
Houston 96
Seattle 90
Cambridge 88
Wilmington 79
Nyköping 61
Dearborn 58
Princeton 56
Como 55
Dublin 52
Rome 48
Ann Arbor 47
Izmir 43
Singapore 41
Boardman 39
Kocaeli 36
Dong Ket 30
Chicago 26
New York 12
Ogden 12
Olomouc 12
Norwalk 11
San Diego 11
Santa Clara 10
Gavirate 7
London 7
Frankfurt am Main 6
Nanjing 5
Perth 5
Vienna 5
Ancona 4
Brussels 4
Busto Arsizio 4
Jinan 4
Los Angeles 4
Washington 4
Beijing 3
Brno 3
Casnate Con Bernate 3
Dallas 3
Dordrecht 3
Garbagnate Milanese 3
Hefei 3
Kilburn 3
Magnago 3
Mentana 3
Padova 3
Redmond 3
Tokyo 3
Vergiate 3
Chengdu 2
Chiswick 2
Helsingborg 2
Helsinki 2
Hong Kong 2
Monza 2
Munich 2
New Bedfont 2
Omegna 2
Ostend 2
Palermo 2
Perugia 2
Prescot 2
Pune 2
Strasbourg 2
Sydney 2
Terzigno 2
Varese 2
Vicenza 2
West Jordan 2
Acton 1
Baotou 1
Dicomano 1
Falkenstein 1
Florence 1
Hounslow 1
Lappeenranta 1
Marche 1
Nervesa della Battaglia 1
Ottawa 1
Riyadh 1
Romola 1
San Jose 1
Shaoxing 1
Shenyang 1
Tappahannock 1
Toronto 1
Valfenera 1
Wandsworth 1
Wenzhou 1
Wuhan 1
Wuxi 1
Zhengzhou 1
Zurich 1
Totale 2.345
Nome #
A novel GABAergic dysfunction in human Dravet syndrome 146
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy 142
Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: results of a randomized, double-blind, controlled study 138
TRP channels expression in Chronic Low Back Pain 130
Cannabis in Epilepsy: from clinical practice to basic research focusing on the possible role of cannabidivarin 127
Changes in the sensitivity of GABAA current rundown to drug treatments in a model of temporal lobe epilepsy 126
Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions 121
Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors 118
Modulation of GABAA receptors in the treatment of epilepsy 115
Fractalkine/CX3CL1 modulates GABAA currents in human temporal lobe epilepsy 114
Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex 109
Physiological characterization of human muscle acetylcholine receptors from ALS patients 108
A novel action of lacosamide on GABAA currents sets the ground for a synergic interaction with levetiracetam in treatment of epilepsy 108
Riluzole blocks human muscle acetylcholine receptors 106
Novel approaches to study the involvement of α7-nAChR in human diseases 103
GABAA currents are decreased by IL-1β in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis 102
Is Betaine a substrate also for GABA transporter 1 (GAT1)? 102
Erythropoietin Increases GABA A Currents in Human Cortex from TLE Patients 101
GABA(A)-current rundown of temporal lobe epilepsy is associated with repetitive activation of GABA(A) "phasic" receptors 100
Characterization of transport activity of SLC11 transporters in Xenopus laevis oocytes by fluorophore quenching 91
Functional characterization of Atlantic salmon (Salmo salar L.) PepT2 transporters 89
The Lepidopteran KAAT1 and CAATCH1: orthologs to understand structure-function relationships in mammalian SLC6 transporters 84
Enhancement of GABA(A)-current run-down in the hippocampus occurs at the first spontaneous seizure in a model of temporal lobe epilepsy 83
Blockage of A(2A) and A(3) adenosine receptors decreases the desensitization of human GABA(A) receptors microtransplanted to Xenopus oocytes 79
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease 65
The role of LRRK2 in the modulation of the glutamate transporter EAAT2 in Parkinson's disease 64
The “www” of Xenopus laevis Oocytes: The Why, When, What of Xenopus laevis Oocytes in Membrane Transporters Research 53
Interview with Cristina Roseti, 2013 Morris-Coole/Epilepsia prize winner (interview by Gary Mathern and Astrid Nehlig) 41
Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism 40
Betaine-The dark knight of the brain 34
The interaction of bile acids with dopamine transporter heterologously expressed in Xenopus laevis oocytes 29
Membranes and synaptosomes used to investigate synaptic GABAergic currents in epileptic patients 8
Totale 2.976
Categoria #
all - tutte 13.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.738


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020368 0 0 0 0 40 77 75 61 47 29 12 27
2020/2021438 10 36 12 33 27 29 36 26 60 70 53 46
2021/2022308 44 36 6 18 9 4 35 18 26 27 49 36
2022/2023424 39 5 40 14 34 82 12 68 64 25 24 17
2023/2024852 131 144 139 146 162 40 7 12 18 8 12 33
2024/2025182 24 9 80 20 49 0 0 0 0 0 0 0
Totale 2.976